The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer
D'Abronzo, L S, Bose, S, Crapuchettes, M E, Beggs, R E, Vinall, R L, Tepper, C G, Siddiqui, S, Mudryj, M, Melgoza, F U, Durbin-Johnson, B P, deVere White, R W, Ghosh, P M
Published in Oncogene (16.11.2017)
Published in Oncogene (16.11.2017)
Get full text
Journal Article